Yuan-Qin Min (Yuanqin Min)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Clinical Evaluation

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan-Qin Min, Wei Xiong, Wei Shen, Xingyu Liu, Qianqian Qi, Yuanyuan Zhang, Ruochen Fan, Fang Fu, Heng Xue, Hang Yang, Xiulian Sun, Yun-Jia Ning, Tian Tian, Xiang Zhou
Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera. Science advances 10 (15) (2024)
Yuan-Qin Min, Wei Xiong, Wei Shen, Xingyu Liu, Qianqian Qi, Yuanyuan Zhang, Ruochen Fan, Fang Fu, Heng Xue, Hang Yang, Xiulian Sun, Yun-Jia Ning, Tian Tian, Xiang Zhou
Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera. Science advances 10 (15) (2024)
Yuan-Qin Min, Wei Xiong, Wei Shen, Xingyu Liu, Qianqian Qi, Yuanyuan Zhang, Ruochen Fan, Fang Fu, Heng Xue, Hang Yang, Xiulian Sun, Yun-Jia Ning, Tian Tian, Xiang Zhou
Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera. Science advances 10 (15) (2024)
Shao-Ru Wang, Yuan-Qin Min, Jia-Qi Wang, Chao-Xing Liu, Bo-Shi Fu, Fan Wu, Ling-Yu Wu, Zhi-Xian Qiao, Yan-Yan Song, Guo-Hua Xu, Zhi-Guo Wu, Gai Huang, Nan-Fang Peng, Rong Huang, Wu-Xiang Mao, Shuang Peng, Yu-Qi Chen, Ying Zhu, Tian Tian, Xiao-Lian Zhang, Xiang Zhou
A highly conserved G-rich consensus sequence in hepatitis C virus core gene represents a new anti-hepatitis C target. Science advances 2 (4) (2016)